RPC4046
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RPC4046, covering 2017-05-09 to 2017-05-09. Get the full timeline:
Most recent: Clinical Trial Update: Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis [Phase 2]